Enrolling Clinical Research Studies
Addiction Medicine
Opioid Use Disorder (OUD)
Opioid Use Disorder
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study with a Separate Open-label Cohort to Evaluate the Efficacy and Safety of Brenipatide as Adjunctive Treatment to Transmucosal Buprenorphine with or without Naloxone in Early Recovery of Participants with Opioid Use Disorder (RENEW-Op-1)
Cardiovascular
Type 2 Diabetes, Hypertension and established Cardiovascular Disease
Type 2 Diabetes and Cardiovascular Risk
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken blood pressure, and cardiovascular disease together with empagliflozin in people with type 2 diabetes, high blood pressure, and cardiovascular disease
Diabetes
Type 1 Diabetes
Type 1 Diabetes
A randomized, double-blind, Phase 3 study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with recently diagnosed Stage 3 Type 1 Diabetes (T1D)
Rheumatology
Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Polymyositis or Dermatomyositis
A Multicenter, Parallel-group, Double-blind, 2-Arm, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared with Placebo Added to Standard of Care in Adult Participants with Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis).
Upcoming Studies
Future Studies
Future Clinical Trials
If you would like to submit your information to be contacted for future study opportunities in Calgary, click to apply here.
Vaccines
Flu
Influenza Vaccine
A phase 3 randomized, observer-blind, controlled study to evaluate the clinical efficacy of an mRNA-based seasonal influenza vaccine in older adults ≥65 years of age.